The iCT Program
Innovative Clinical Trials (iCT) Program
Chronic diseases are associated with shorter lifespans, frequent contact with the health care system, and reduced quality of life. New ways of delivering health services are needed to promote health and ensure consistent, high-quality care for Canadians living with chronic conditions. It is important, however, that new interventions and strategies are carefully studied to ensure they benefit patients and provide value.
Over the next four years, our team will test health innovations and interventions that improve care, safety and outcomes for people with three common and closely related chronic diseases: heart disease, diabetes and kidney disease.
There are three main studies that will be the focus:
IMPROVE
This study examines the way patients' symptoms and experiences are recorded, communicated, and acted upon during doctors’ visits, and whether an intervention to help report these symptoms improves patient outcomes and experiences
AIM
This study is evaluating the impact of using electronic health record systems (how doctors and hospitals collect health information and use it to deliver care) on patients’ experiences and outcomes in various settings across Alberta
PAUSE
PAUSE is a mobile health intervention that provides patients with guidance on managing their medications when they are sick so they can avoid severe complications.